Uncategorized
MichBio Joins Medtech Partners in Asking Congress to Pass H.R. 1691
MichBio joined AdvaMed, MDMA, as well as fellow state medtech associations and other stakeholders in a letter seeking Congressional passage of H.R. 1691, the Ensuring Access to Critical Breakthrough Products Act. It comes on the heels of the Centers for Medicare & Medicaid Services (CMS) issuing its final rule back in August 2024 on the…
Read MoreCMS Finalizes Expedited TCET Coverage Pathway
The Centers for Medicare & Medicaid Services (CMS) finalized a new Transitional Coverage for Emerging Technologies (TCET) Pathway to expedite Medicare coverage of some FDA-approved breakthrough products. Under this finalized pathway, eligible US Food and Drug Administration (FDA) designated breakthrough devices that fall within a Medicare benefit category can obtain national coverage for several years…
Read MoreIndependent Contractor or Employee? It’s Time for Employers to Reassess.
By Melvin J. Muskovitz, Esq. The U. S. Department of Labor (DOL) has issued a new rule addressing worker classification under the Fair Labor Standards Act (FLSA). While the rule, which went into effect on March 11, 2024, has some aspects that favor employers, it is intended to narrow the scope of workers deemed to…
Read MoreMichBio Hosts Inaugural Life Sciences Legislative Academy
MichBio hosted a unique and exclusive event for legislators, a Michigan Life Sciences Legislative Academy, wherein bio-industry leaders gathered to educate elected officials about the life sciences ecosystem in Michigan, its economics, and unique needs of the industry, as well as pressing issues related to serving patients, developing treatments, and improving the quality of life…
Read MoreReflections on 2023
As 2023 ends, we’ve been reflecting on the impact our team made on Michigan’s life sciences industry. While there were certainly challenges along the way, we’re proud of the work done here at MichBio and hope you’ve noticed our efforts to convene, connect, inform, and advocate for the statewide life sciences cluster. Some reflections on…
Read MoreLetter to President Biden Regarding Mexico Treatment of Agricultural Biotechnology
MichBio joined other state and federal partners in a letter to President Biden ahead of his recent meeting with the leaders of Mexico and Canada. It requested that the U.S. government engage the Government of Mexico at the highest levels to address its recent actions affecting agricultural biotechnology and trade of U.S. agricultural products produced…
Read MoreNew CDC Data: COVID-19 Vaccination Safe for Pregnant People
Original Source CDC has released new data on the safety of the COVID-19 vaccines in pregnant people and is recommending all people 12 years of age and older get vaccinated against COVID-19. “CDC encourages all pregnant people or people who are thinking about becoming pregnant and those breastfeeding to get vaccinated to protect themselves from COVID-19,” said…
Read MorePhilippines Approves GMO ‘Golden Rice’ for Commercial Production
Original Source The Philippines became the world’s first country Friday to approve the commercial production of genetically modified “golden rice” that experts hope will combat childhood blindness and save lives in the developing world. A biosafety permit issued by government regulators paves the way for the rice — enriched with the vitamin A precursor beta-carotene…
Read MoreStrata Oncology Completes $90 Million Series C Financing
Original Source Funding will accelerate ongoing development of tissue and blood tests to broaden the reach and impact of precision medicine for patients with cancer ANN ARBOR, Mich., July 28, 2021 – Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced the completion of a $90 million Series C financing,…
Read MoreSanofi to help manufacture Moderna COVID-19 vaccine, supporting global supply demands
Sanofi is the only company to leverage its manufacturing capacity and expertise to support three different COVID-19 vaccines to support the global supply of vaccines and help address the pandemic Sanofi to manufacture up to 200 million doses of Moderna’s vaccine in the U.S. starting in September 2021 MEDIA UPDATE – April 26, 2021 Sanofi…
Read More